Critical and opposing roles of the chemokine receptors CXCR2 and CXCR3 in prostate tumor growth
- 29 August 2006
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 66 (16) , 1721-1728
- https://doi.org/10.1002/pros.20476
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- CXC chemokines in angiogenesisCytokine & Growth Factor Reviews, 2005
- The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycanMolecular Therapy, 2004
- Progressive dysregulation of transcription factors NF-κB and STAT1 in prostate cancer cells causes proangiogenic production of CXC chemokinesAmerican Journal of Physiology-Cell Physiology, 2004
- Angiogenic Effects of Interleukin 8 (CXCL8) in Human Intestinal Microvascular Endothelial Cells Are Mediated by CXCR2Journal of Biological Chemistry, 2003
- Cell cycle–dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activityJournal of Clinical Investigation, 2001
- Differential expression and responsiveness of chemokine receptors (CXCR1–3) by human microvascular endothelial cells and umbilical vein endothelial cellsThe FASEB Journal, 2000
- Distinct CXC Chemokines Mediate Tumorigenicity of Prostate Cancer CellsThe American Journal of Pathology, 1999
- The Regulation of Neovascularization by Matrix Metalloproteinases and Their InhibitorsThe International Journal of Cell Cloning, 1997
- Interferon-inducible protein-10 identified as a mediator of tumor necrosisin vivoProceedings of the National Academy of Sciences, 1996
- The Functional Role of the ELR Motif in CXC Chemokine-mediated AngiogenesisJournal of Biological Chemistry, 1995